Jan. 10, 2025
We updated multiple Laboratory Management Payment and Coding Policies with a new code released by the American Medical Association, effective Jan. 1, 2025.
These CPCPs are updated:
- CPCP 002 Cervical Cancer Screening
- CPCP 011 Biomarker Testing for Autoimmune Rheumatic Disease
- CPCP 018 Helicobacter pylori Testing
- CPCP 027 Testing for Diagnosis of Active or Latent Tuberculosis
- CPCP 030 In Vitro Chemoresistance and Chemosensitivity Assays
- CPCP 036 Serum Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases
- CPCP 045 Pathogen Panel Testing
- CPCP 052 β − Hemolytic Streptococcus Testing
- CPCP 059 Diagnosis of Vaginitis
For more details, refer to the revised policies in Availity® Essentials through the Plan Documents Viewer application. You can access the application in Payer Spaces for Blue Cross and Blue Shield of Montana.
The information provided does not constitute coding or legal advice. Physicians and other health care providers should use their own medical judgment based upon all available information and the condition of the patient in determining the appropriate course of treatment, and to submit claims using the most appropriate code(s) based upon the medical record documentation, coding guidelines and reference materials.
Availity is a trademark of Availity, LLC, a separate company that operates a health information network to provide electronic information exchange services to medical professionals. Availity provides administrative services to BCBSMT. BCBSMT makes no endorsement, representations or warranties regarding third party vendors and the products and services they offer.